HYPERTHERMIA CANCER TREATMENT

What is HEATT®?

Verthermia® provides Hyperthermic Extracorporeal Applied Tumor Therapy (HEATT®), a patented, whole-body hyperthermia cancer treatment to extend and enhance daily living in end-stage cancer patients.

GET STARTED

INCREASING IMMUNITY AND KILLING CANCER CELLS

The HEATT® Procedure

For over thirty years, Verthermia® has worked to perfect the procedure of HEATT®. We prioritize safety by closely monitoring vitals during the entire cancer treatment procedure as we heat the body. With this heat, we target cancerous cells as blood circulates. HEATT® also results in a positive immune response, which enhances the body's defense system.

READ PATIENT TESTIMONIALS

Why 42° Celsius?

42° C has been scientifically identified as an optimal temperature because it can damage cancer cells while providing minimal harm to healthy cells.

INNOVATIVE TECHNOLOGY

Our HEATT® Circuit

With years of scientific research, Verthermia® has perfected the procedure of HEATT® with the use of our transformational whole-body hyperthermia machine and system. Our HEATT® circuit is a heart and lung machine with a recirculating dialysate system, charcoal filtration and pCO2/pH control, which are all FDA-approved components. The HEATT® procedure circulates blood throughout the body at 20 percent cardiac output for 50 minutes to heat the patient's blood. As we continue to monitor the patient, we maintain the temperature of the blood at 42° C for two hours while cancer cells are destroyed or damaged. Using our HEATT® system, we are able to utilize a unique combination of advanced safety features, comprehensive monitoring tools, and precise delivery technology to ensure that each patient receives the best and safest possible whole-body hyperthermia cancer treatment.

THE SCIENCE OF HEATT®

NON-INVASIVE CANCER TREATMENT

Our HEATT® Treatment Process>

We understand that choosing a cancer treatment can be overwhelming, but at Verthermia®, we are confident in the benefits of whole-body hyperthermia and its potential to improve your quality of life. We ensure that all patients understand the process before undergoing treatment to provide knowledge and peace of mind. Throughout this non-invasive procedure, the patient is also placed under anesthesia to ensure ultimate comfort.

Administration of Anesthesia

The patient is put under general anesthesia to avoid discomfort throughout the procedure.

Blood is Heated

The blood is withdrawn then heated by a proprietary patented therapy (HEATT®) using FDA-approved devices in an external circuit. The heated blood is then returned within a large vein to the right heart.

Distribution of Heat

The right heart pumps the blood to the lungs, which act like a radiator to evenly distribute the heat then return blood to the left heart.

Patient Body is Heated

The left heart pumps the heated blood to the whole body including insulated and isolated areas (i.e. brain, bone marrow, mediastinum).

Detoxification of Blood

Using dialysis to restore and balance the body’s natural chemistry, the blood is then detoxified by a filter.

Cancer Cell Suppression

HEATT® potentially kills or suppresses cancer cells in all parts of the body by heating the body to 42º C (or 107.6 Fahrenheit) for 120 minutes.

LEARN MORE ABOUT HEATT®

Verthermia® Webinars

To provide our patients with the best possible care, we offer a range of educational webinars and online resources about HEATT®. Our expert panelists and oncologists discuss topics such as the hyperthermia therapy process, all-encompassing trial results, patient success stories, and much more.

CANDIDACY REQUIREMENTS

Who Can Benefit from HEATT®?

At Verthermia®, we are dedicated to providing patients with the absolute highest standard of care and safety. We follow strict guidelines so every patient who undergoes whole-body hyperthermia cancer treatment will do so safely to minimize complications. To be a candidate for HEATT®, a patient must meet certain criteria. Contact us today to further discuss your eligibility.

The patient must be over 18 years of age to obtain treatment.

The patient must have an advanced cancer diagnosis.

The patient must be unresponsive to conventional treatments.

The patient has not had a stroke or heart attack in the past 6 months.

The patient has not received recent chemotherapy that could interfere.

FIND OUT IF YOU ARE QUALIFIED

THE VERTHERMIA® DIFFERENCE

Revolutionizing Cancer Treatment

The main difference between HEATT® and other hyperthermia treatments is that we heat the blood directly and tightly control body temperature while normalizing fluids, electrolytes, and pH balance. HEATT® uses the patient's own blood for whole-body hyperthermia to conduct heat rather than using typical conduction or convection methods.

ABOUT VERTHERMIA®

FURTHERING TREATMENT SUCCESS

When to Consider HEATT®

We recommend HEATT® when conventional cancer treatments no longer provide benefit or effectiveness for a patient. HEATT® therapy is not a replacement for conventional treatments, such as radiation and chemotherapy. HEATT® is a complementary therapy option that has shown great promise in scientific studies. Research is also being conducted on how hyperthermia may increase the success of further conventional therapies.

CONTACT US TODAY

LEARN MORE ABOUT HEATT®

Frequently Asked Questions

We understand that you may have some questions about our whole-body hyperthermia cancer treatment. We are here to answer your questions and provide information to make sure you feel comfortable with the process. We have compiled commonly asked questions to address your initial concerns.

What is the recovery time for HEATT®?

Although side effects from HEATT® are typically minimal, suggested recovery time is about 2 days in a supervised setting. If a patient is experiencing problems associated with advanced cancer symptoms or previous treatments, the time frame or supervision may be increased.

How often is HEATT® needed?

In recent studies, we have evaluated the responses of both singular and repetitive HEATT® treatments in patients. As we continue to evaluate the ideal number of HEATT® treatments, we recommend one treatment to assess the response before potentially returning to conventional cancer treatment or repeating HEATT®.

Does hyperthermia cure cancer?

Whole-body hyperthermia is a treatment option that has shown safety and efficacy in select advanced cancer patients. While it does not cure cancer, our trials show the potential to reduce the severity and spread of many cancers.

Is hyperthermia cancer treatment safe?

HEATT® circulates and heats the patient’s own blood. The patient is managed in a controlled setting by a team of specialists trained to administer the procedure safely. Like any procedure, there are some risks which will be discussed prior to treatment. Contact the Verthermia® team today to discuss any concerns.

What types of cancers are treated with HEATT®?

HEATT® has been found to be effective in treating various forms of advanced cancer including ovarian, lung, and other solid cancers.

Who conducts the HEATT® procedure?

HEATT® is performed by a team of experienced medical professionals, including physicians, nurses, and technicians.

How do I prepare for my hyperthermia cancer treatment?

Before you begin HEATT®, your healthcare provider will communicate instructions on how to best prepare for the treatment. For example, maintaining activity, avoiding certain foods and drinks, increasing your fluid intake, and taking medications. Follow these instructions, as directed by your provider, in order to ensure the best outcome from the treatment. You may be told to stop certain medications prior to HEATT®.

LEARN MORE ABOUT HEATT®

Our Cancer Treatment Blog

Stay up to date on the latest topics and trends in whole-body hyperthermia cancer treatment. Learn more about helpful information, tips, and resources for those affected by cancer or considering HEATT®.

VIEW ALL BLOGS

Hyperthermia Cancer Treatment: HEATT® and Clinical Insights

Hyperthermia cancer treatment is a promising approach in the field of oncology, offering potential benefits for patients suffering from advanced-stage […]

Clinical Trial: Ovarian Cancer Overview

The Verthermia® team conducted an FDA Phase 1 clinical trial during 2014-2015, resulting in significant findings on the positive impact […]

Ovarian Cancer Trial Results: Cell Destruction

The image on the left shows the tumors at the beginning of the study. The image on the right shows […]